Back to search

Article

Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma

2022-12-08

Abstract excerpt

<h4>ABSTRACT</h4> Pseudo-progression and flare-up phenomena constitute a novel diagnostic challenge in the follow-up of patients treated with immune-oncology drugs. We present a case study on pulmonary flare-up after Idecabtagen Vicleucel (Ide-cel), a BCMA targeting CAR T-cell therapy, and used single-cell RNA-seq (scRNA-seq) to identify a Th17.1 driven autoimmune mechanism as the biological underpinning of this p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c3bd2ca-7719-5b37-addd-2b3ab60f4d74
DOI
10.1101/2022.12.08.22283148
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myelomaDOI 10.1101/2022.12.08.22283148
Select a neighboring publication to make it the new centre.